Globus Medical Announces Appointment of Orthopedic Trauma Division’s Vice President of Sales

AUDUBON, Pa., May 21, 2018 (GLOBE NEWSWIRE) — Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced the appointment of Daniel Gregoris to Vice President of Sales for the company’s emerging Orthopedic Trauma division.  Gregoris will be responsible for leading the growth and expansion of Globus Medical’s direct Trauma sales force and the development and execution of all domestic sales strategies within the Trauma business unit.

“Dan shares the company’s values and passion for continuous product innovation and exceptional customer responsiveness,” said Chief Executive Officer Dave Demski.  “His extensive experience in sales management, expertise in the orthopedic trauma space, and proven track record of building dynamic and highly successful sales teams make him an excellent choice to lead our trauma sales force as they enter this new market.”

Prior to joining Globus Medical, Gregoris served as Area Vice President of Sales for DePuy Synthes Trauma, a subsidiary of Johnson and Johnson, and brings over 20 years of combined sales and sales management experience in the orthopedic trauma market.

“I’m so excited to lead the trauma sales efforts for a company with a strong history in quality products and service that truly help surgeons and healthcare systems advance patient care,” Gregoris said. “I am passionate about medical devices and this is where I have spent my entire career. I look forward to leveraging my more than two decades of sales experience and relationships with the Globus commitment to enter and advance orthopedic trauma.”

About Globus Medical, Inc.
Globus Medical, Inc. is a leading musculoskeletal solutions company based in Audubon, PA. The company was founded in 2003 by an experienced team of professionals with a shared vision to create products that enable surgeons to promote healing in patients with musculoskeletal disorders. Additional information can be accessed at http://www.globusmedical.com.

Safe Harbor Statements
All statements included in this press release other than statements of historical fact are forward-looking statements and may be identified by their use of words such as “believe,” “may,” “might,” “could,” “will,” “aim,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” “plan” and other similar terms. These forward-looking statements are based on our current assumptions, expectations and estimates of future events and trends. Forward-looking statements are only predictions and are subject to many risks, uncertainties and other factors that may affect our businesses and operations and could cause actual results to differ materially from those predicted. These risks and uncertainties include, but are not limited to, factors affecting our quarterly results, our ability to manage our growth, our ability to sustain our profitability, demand for our products, our ability to compete successfully (including without limitation our ability to convince surgeons to use our products and our ability to attract and retain sales and other personnel), our ability to rapidly develop and introduce new products, our ability to develop and execute on successful business strategies, our ability to comply with changing laws and regulations that are applicable to our businesses, our ability to safeguard our intellectual property, our success in defending legal proceedings brought against us, trends in the medical device industry, general economic conditions, and other risks. For a discussion of these and other risks, uncertainties and other factors that could affect our results, you should refer to the disclosure contained in our most recent annual report on Form 10-K filed with the Securities and Exchange Commission, including the sections labeled “Risk Factors” and “Cautionary Note Concerning Forward-Looking Statements,” and in our Forms 10-Q, Forms 8-K and other filings with the Securities and Exchange Commission. These documents are available at www.sec.gov. Moreover, we operate in an evolving environment. New risk factors and uncertainties emerge from time to time and it is not possible for us to predict all risk factors and uncertainties, nor can we assess the impact of all factors on its business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. Given these risks and uncertainties, readers are cautioned not to place undue reliance on any forward-looking statements. Forward-looking statements contained in this press release speak only as of the date of this press release. We undertake no obligation to update any forward-looking statements as a result of new information, events or circumstances or other factors arising or coming to our attention after the date hereof.

Contact:
Brian Kearns
Vice President, Business Development and Investor Relations
Phone: (610) 930-1800
Email:  investors@globusmedical.com
www.globusmedical.com